|
|
Volumn 74, Issue 13, 2014, Pages 1509-1522
|
|
Fluticasone furoate/vilanterol: a review of its use in chronic obstructive pulmonary disease
a
a
NONE
(New Zealand)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANDROSTANE DERIVATIVE;
BENZYL ALCOHOL DERIVATIVE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
CHLOROBENZENE;
DELAYED RELEASE FORMULATION;
DRUG COMBINATION;
FLUTICASONE FUROATE;
GLUCOCORTICOID;
VILANTEROL;
COMPARATIVE STUDY;
DELAYED RELEASE FORMULATION;
DRUG COMBINATION;
DRY POWDER INHALER;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MEDICATION COMPLIANCE;
PATHOPHYSIOLOGY;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
SEVERITY OF ILLNESS INDEX;
ADMINISTRATION, INHALATION;
ADRENERGIC BETA-2 RECEPTOR AGONISTS;
ANDROSTADIENES;
BENZYL ALCOHOLS;
CHLOROBENZENES;
DELAYED-ACTION PREPARATIONS;
DRUG COMBINATIONS;
DRY POWDER INHALERS;
GLUCOCORTICOIDS;
HUMANS;
MEDICATION ADHERENCE;
PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;
SEVERITY OF ILLNESS INDEX;
|
|
EID: 85027943492
PISSN: 00126667
EISSN: None
Source Type: Journal
DOI: 10.1007/s40265-014-0269-6 Document Type: Article |
|
Times cited : (13)
|
|
References (0)
|